The US OTC drugs market thrives, driven by increasing self-medication trends, diverse product offerings, and growing health ...

Union Minister of State for Health and Family Welfare Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias ...

On January 7, 2025, the US Food and Drug Administration (FDA) issued two parallel guidance documents for the Section 503A and Section 503B bulk ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...

Even so, this relatively lean state had among the nation’s biggest surges last year in residents taking blockbuster weight-loss drugs, and the trend shows no signs of abating. About 140,400 ...

The reauthorization of OMUFA, the over-the-counter monograph drug user fee program, could serve as a platform for addressing issues like drug shortages and FDA policy changes. Drug pricing and ...

There is no approved treatment for high Lp(a), but five drugs are in development, and last fall, two of them – Muvalaplin and Zerlasiran – moved a step closer to consideration by the FDA.